Leerink cuts BioNTech stock price target on drug trial concerns.
Share this article
Corporate
Score 45
Bearish
Leerink cuts BioNTech stock price target on drug trial concerns
Apr 07, 2026 11:11 UTC
BNTX
Short term
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.